DGAP-PVR: STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

        Print
| Source: EQS Group AG
STRATEC Biomedical AG 

30.04.2014 18:33

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


1. Tanja van Dinter, Germany, notified us pursuant to sec 21 para 1 of the
German Securities Trading Act (WpHG) that her share of the voting rights in
STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the thresholds of 15,
20 and 25% on April 27, 2014 and amounted to 29.53% on this date (3,476,286
voting rights). Of these, 20.16% (2,373,333 voting rights) were
attributable to her pursuant to sec. 22 para 2 WpHG via Herdor GmbH & Co.
KG, Bettina Siegle and Ralf Leistner, which all hold at least 3% of the
voting rights.

2. Bettina Siegle, Germany, notified us pursuant to sec. 21 para 1 of the
German Securities Trading Act (WpHG) that her share of the voting rights in
STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the thresholds of 15,
20 and 25% on April 27, 2014 and amounted to 29.68% on this date (3,493,954
voting rights). Of these, 20.16% (2,373,333 voting rights) were
attributable to her pursuant to sec. 22 para 2 WpHG via Herdor GmbH & Co.
KG, Tanja van Dinter and Ralf Leistner, which all hold at least 3% of the
voting rights.

3. Ralf Leistner, Germany, notified us pursuant to sec. 21 para 1 of the
German Securities Trading Act (WpHG) that his share of the voting rights in
STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the thresholds of 15,
20 and 25% on April 27, 2014 and amounted to 29.73% on this date (3,499,343
voting rights). Of these, 20.16% (2,373,334 voting rights) were
attributable to him pursuant to sec. 22 para 2 WpHG via Herdor GmbH & Co.
KG, Tanja van Dinter and Bettina Siegle, which all hold at least 3% of the
voting rights.

4. Hermann Leistner, Germany, notified us pursuant to sec. 21 para 1 of the
German Securities Trading Act (WpHG) that his share of the voting rights in
STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the thresholds of 15,
20 and 25% on April 27, 2014 and amounted to 25.79% on this date (3,035,456
voting rights). Of these, 25.40% (2,990,000 voting rights) were
attributable to him pursuant both to sec. 22 para 1 sentence 1 no. 1 WpHG
and to sec. 22 para 2 WpHG via Herdor Beteiligungs GmbH, Herdor GmbH & Co.
KG, Tanja van Dinter, Bettina Siegle and Ralf Leistner, which all hold at
least 3% of the voting rights.

5. Doris Leistner, Germany, notified us pursuant to sec. 21 para 1 of the
German Securities Trading Act (WpHG) that her share of the voting rights in
STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the thresholds of 15,
20 and 25% on April 27, 2014 and amounted to 25.74% on this date (3,030,235
voting rights). Of these, 25.40% (2,990,000 voting rights) were
attributable to her pursuant both to sec. 22 para 1 sentence 1 no. 1 WpHG
and to sec. 22 para 2 WpHG via Herdor Beteiligungs GmbH, Herdor GmbH & Co.
KG, Tanja van Dinter, Bettina Siegle and Ralf Leistner, which all hold at
least 3% of the voting rights.

6. Herdor GmbH & Co. KG, Germany, notified us pursuant to sec 21 para 1 of
the German Securities Trading Act (WpHG) that its share of the voting
rights in STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the
thresholds of 10, 15, 20 and 25% on April 27, 2014 and amounted to 25.40%
on this date (2,990,000 voting rights). Of these, 15.72% (1,850,000 voting
rights) were attributable to it pursuant to sec. 22 para 2 WpHG via Tanja
van Dinter, Bettina Siegle and Ralf Leistner, which all hold at least 3% of
the voting rights.

7. Herdor Beteiligungs GmbH, Germany, notified us pursuant to sec. 21 para
1 of the German Securities Trading Act (WpHG) that its share of the voting
rights in STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the
thresholds of 10, 15, 20 and 25% on April 27, 2014 and amounted to 25.40%
on this date (2,990,000 voting rights). Of these, 25.40% (2.990,000 voting
rights) were attributable to it pursuant both to sec. 22 para 1 sentence 1
no. 1 WpHG and to sec. 22 para 2 WpHG via Herdor GmbH & Co. KG, Tanja van
Dinter, Bettina Siegle and Ralf Leistner, which all hold at least 3% of the
voting rights.



30.04.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------